Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07337174
PHASE1
Study to Compare and Evaluate the Safety and Pharmacokinetics After Subcutaneous Injection of HUC2-676 or HUC2-676-R in Healthy Adult Subjects
Sponsor: Huons Co., Ltd.
View on ClinicalTrials.gov
Summary
The trial uses a randomized, open-label, single-dose administration per period, and a 2 x 2 crossover design where subjects receive both treatments sequentially with a washout.
Official title: A Randomized, Open-label, Single Dose, Two-way, Crossover, Phase 1 Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics After Subcutaneous Injection of HUC2-676 or HUC2-676-R in Healthy Adult Subjects
Key Details
Gender
All
Age Range
19 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2026-01-25
Completion Date
2026-03-24
Last Updated
2026-01-13
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
HUC2-676
subcutaneous injection
DRUG
HUC2-676-R
subcutaneous injection